ABELCET Drug Patent Profile
✉ Email this page to a colleague
When do Abelcet patents expire, and what generic alternatives are available?
Abelcet is a drug marketed by Leadiant Biosci Inc and is included in one NDA.
The generic ingredient in ABELCET is amphotericin b. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amphotericin b profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Abelcet
A generic version of ABELCET was approved as amphotericin b by XGEN PHARMS on April 29th, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ABELCET?
- What are the global sales for ABELCET?
- What is Average Wholesale Price for ABELCET?
Summary for ABELCET
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 62 |
Clinical Trials: | 3 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ABELCET |
What excipients (inactive ingredients) are in ABELCET? | ABELCET excipients list |
DailyMed Link: | ABELCET at DailyMed |
![ABELCET drug patent expirations Drug patent expirations by year for ABELCET](/p/graph/s/t/ABELCET-patent-expirations.png)
![Drug Prices for ABELCET](/p/graph/drug-price/ABELCET.png)
US Patents and Regulatory Information for ABELCET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leadiant Biosci Inc | ABELCET | amphotericin b | INJECTABLE, LIPID COMPLEX;INJECTION | 050724-001 | Nov 20, 1995 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ABELCET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Leadiant Biosci Inc | ABELCET | amphotericin b | INJECTABLE, LIPID COMPLEX;INJECTION | 050724-001 | Nov 20, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Leadiant Biosci Inc | ABELCET | amphotericin b | INJECTABLE, LIPID COMPLEX;INJECTION | 050724-001 | Nov 20, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ABELCET
See the table below for patents covering ABELCET around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Greece | 3015916 | ⤷ Sign Up | |
Japan | H02502460 | ⤷ Sign Up | |
World Intellectual Property Organization (WIPO) | 8806443 | ⤷ Sign Up | |
Mexico | 9203800 | SISTEMAS DE DROGA DE BAJA TOXICIDAD-LIPIDO. | ⤷ Sign Up |
Hungary | 209647 | PROCESS FOR PRODUCTION OF LOW TOXICITY COMPOSITION CONTAINING BIOACTIVE AGENT AND LIPID | ⤷ Sign Up |
Denmark | 176010 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |